Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
3 Gene Editing Stocks to Buy Now OR You'll Be Kicking Yourself Later
05:20pm, Wednesday, 25'th Jan 2023
To many investors, gene editing sounds like the plot of a science fiction movie. The concept of being able to edit our DNA to cure genetic diseases is quite unbelievable, and the upside of gene editin
3 Reasons to Buy AbbVie and 2 Reasons Not to Buy
12:05pm, Wednesday, 25'th Jan 2023 The Motley Fool
The pharmaceutical specialist is facing a pivotal year in 2023, thanks to growing competition.
Want Safety and Growth in 2023? Try These Dividend Stocks.
11:00am, Wednesday, 25'th Jan 2023 The Motley Fool
Passive income is particularly welcome during tough market times.
3 Reasons to Buy AbbVie and 2 Reasons Not to Buy
07:05am, Wednesday, 25'th Jan 2023
The pharmaceutical specialist is facing a pivotal year in 2023, thanks to growing competition.
Want Safety and Growth in 2023? Try These Dividend Stocks.
06:00am, Wednesday, 25'th Jan 2023
Passive income is particularly welcome during tough market times.
The Dividend Kings Ranked By Quality Score
09:15am, Tuesday, 24'th Jan 2023
Dividend Kings have an astounding track record of 50 or more years of higher dividend payouts. I rank the Dividend Kings using Quality Snapshots, a simple yet elegant system for assessing the quality
3 Irresistible Dividend Kings
08:00am, Tuesday, 24'th Jan 2023
I'm starting this article with a theoretical background explaining the benefits that come with high-quality dividends. We dive into empirical evidence supporting a wide variety of dividend strategies.
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know
10:45pm, Monday, 23'rd Jan 2023 Zacks Investment Research
In the latest trading session, AbbVie (ABBV) closed at $148.55, marking a -0.7% move from the previous day.
Selecting Dividend Aristocrats Using SCHD Methodology - Slow And Steady
10:16pm, Monday, 23'rd Jan 2023
I propose leveraging the stock selection criteria from the underlying index of SCHD to build a portfolio with a subset of Dividend Aristocrats. I am tracking two portfolios built using this process an
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
02:00pm, Monday, 23'rd Jan 2023 Zacks Investment Research
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Charles River Laboratories, AbbVie, Star Bulk Carriers And This Big Bank Are CNBC's 'Final Trades'
01:40pm, Monday, 23'rd Jan 2023 Benzinga
On CNBC’s "Halftime Report Final Trades," Jason Snipe of Odyssey Capital Advisors said Charles River Laboratories International, Inc. (NYSE: CRL) is trading at 20 time earnings and has a strong fre
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
10:32am, Monday, 23'rd Jan 2023
AbbVie (ABBV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
2 Top Passive-Income Stocks to Own in 2023
12:05am, Monday, 23'rd Jan 2023 The Motley Fool
These dividend stocks can deliver both downside protection and capital appreciation.
Ranking The Diversified Healthcare Giants
10:53pm, Sunday, 22'nd Jan 2023
The Top Six Healthcare Products and Service companies are some of the most popular investments in the market. However, they offer varying financial profiles.
2 Top Passive-Income Stocks to Own in 2023
07:05pm, Sunday, 22'nd Jan 2023
These dividend stocks can deliver both downside protection and capital appreciation.
